Juntendo, Kao and PFN Discover Skin Surface Lipids-RNA Patterns Specific to Patients with Parkinson’s Disease

PFN Develops AI Drug Discovery Technology That Accelerates Initial Screening for Pharmaceutical Development

Curreio and PFN Collaborate on Drug Discovery Using Deep Learning and Structural Analysis

Preferred Networks Uses Deep Learning to Help Kyoto Physicians Diagnose Lung Cancer from Chest X-Ray Images

Kao and Preferred Networks Launch a Collaborative Project for Practical Applications of Sebum RNA Monitoring Technology

Preferred Networks and PFDeNA launch joint research project to develop a deep learning-based system to detect 14 types of cancers with a small amount of blood

Preferred Networks raises a total of about 900 million yen in capital from Chugai Pharmaceutical and Tokyo Electron